EP 2076126 A4 20111228 - NOVEL COMBINATIONS OF DNAK INHIBITORS WITH KNOWN ANTIBACTERIAL AGENTS
Title (en)
NOVEL COMBINATIONS OF DNAK INHIBITORS WITH KNOWN ANTIBACTERIAL AGENTS
Title (de)
NEUE KOMBINATIONEN VON DNAK-HEMMERN MIT BEKANNTEN ANTIBAKTERIELLEN MITTELN
Title (fr)
NOUVELLES COMBINAISONS D'INHIBITEURS DE DNAK AVEC DES AGENTS ANTIBACTÉRIENS CONNUS
Publication
Application
Priority
US 2006035272 W 20060912
Abstract (en)
[origin: WO2008033119A1] Compositions, methods and kits are provided comprising (a) a therapeutically effective amount of a DnaK inhibitor; and (b) a therapeutically effective amount of a known antibacterial agent. Such compositions, methods and kits are useful in the treatment of various bacterial infections.
IPC 8 full level
A01N 37/18 (2006.01); A61K 38/10 (2006.01); A61P 31/04 (2006.01)
CPC (source: EP US)
A61K 38/10 (2013.01 - EP US); A61P 31/04 (2017.12 - EP); Y02A 50/30 (2017.12 - EP)
Citation (search report)
- [XY] WO 0078956 A1 20001228 - WISTAR INST [US], et al
- [XY] US 2003108957 A1 20030612 - OTVOS LASZLO [US], et al
- [Y] CUDIC M ET AL: "In vitro and in vivo activity of an antibacterial peptide analog against uropathogens", PEPTIDES, ELSEVIER, AMSTERDAM, vol. 24, 1 January 2003 (2003-01-01), pages 807 - 820, XP002329691, ISSN: 0196-9781, DOI: 10.1016/S0196-9781(03)00172-4
- [Y] YAMAGUCHI YUKO ET AL: "Effects of disruption of heat shock genes on susceptibility of Escherichia coli to fluoroquinolones", BMC MICROBIOLOGY, BIOMED CENTRAL, LONDON, GB, vol. 3, no. 1, 12 August 2003 (2003-08-12), pages 16, XP021002539, ISSN: 1471-2180, DOI: 10.1186/1471-2180-3-16
- See references of WO 2008033119A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2008033119 A1 20080320; EP 2076126 A1 20090708; EP 2076126 A4 20111228
DOCDB simple family (application)
US 2006035272 W 20060912; EP 06824922 A 20060912